Equillium Price Target Maintained at $12 by Roth Capital

Author: Robert Ashcroft

Equillium Price Target Maintained at $12 by Roth Capital

Roth Capital has maintained its $12 per share price target for Equillium (NASDAQ: EQ). The assessment is based on the company's current market performance and future prospects.

Analyst Outlook

Roth Capital analysts view Equillium's potential positively and reaffirm the $12 price target. This provides a key reference point for investors.

Market Reaction

Following the news, Equillium shares are expected to see movement. Investors closely monitor analyst reports to shape their decisions.

Impacted Symbols

Symbols affected by this headline and their sentiment signals

The news, analyses, and comments on this platform do not constitute investment advice. When making investment decisions, you should conduct your own research and consult with a qualified financial advisor if necessary. FiNews cannot be held responsible for any losses that may arise from the use of this information.

More Headlines

Equillium Price Target Maintained at $12 by Roth Capital - FiNews